Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer,
Location: Dallas TX, St Louis MO, Nashville TN, Greenville SC,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07545811
Phase1, Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
for
Advanced HR+/HER2- Breast Cancer
Location: Dallas TX, Toronto, New Haven CT
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07604571
Phase1, Recruiting
Study of STP938 (Dencatistat) in Advanced Solid Tumours
for
Solid Tumor
Location: Dallas TX, San Antonio TX, St. Petersburg FL
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT06297525
Phase1, Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Dallas TX, Arlington TX, Cypress TX, Fort Smith AR,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06947993
Phase2, Recruiting
Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)
for
Degenerative Joint Disease of Shoulder
Location: Rockwall TX
Sponsor: North Texas Medical Research Institute, PLLC
Sex: All
Age: 30 - 70+
Code: NCT07125833
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Asciminib Roll-over Study
for
Chronic Myelogenous Leukemia,
Location: Dallas TX, Houston TX, Milwaukee WI, Ann Arbor MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 7 - 70+
Code: NCT04877522
Recruiting
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
for
Carcinoma, Squamous Cell
Location: Dallas TX, Houston TX, Little Rock AR, Aurora CO,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041626
Phase3, Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Location: Dallas TX, Houston TX, Detroit MI, Silver Spring MD
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase1, Recruiting
Recovery Through Inspiration, Support, and Empowerment
for
Suicidal Ideation, Suicide Attempt, Anxiety,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 27
Code: NCT07051200
Recruiting
SW-682 in Advanced Solid Tumors
for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Dallas TX, Houston TX, Scottsdale AZ, Cleveland OH,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06251310
Phase1, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
for
Multiple Myeloma
Location: Dallas TX, Denver CO, Atlanta GA, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06892522
Phase1, Phase2, Recruiting
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA
Sponsor: 1200 Pharma, LLC
Sex: All
Age: 18+
Code: NCT05103046
Phase1, Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
for
Solid Tumors, ER+ Breast Cancer,
Location: Dallas TX, St Louis MO, Salt Lake City UT, Detroit MI
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT05490472
Phase1, Phase2, Recruiting
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Fairway KS, Atlanta GA,
Sponsor: Impact Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04768868
Phase1, Recruiting
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
for
Advanced Cancer, Metastatic Cancer
Location: Dallas TX, Chicago IL, Rochester MN, Phoenix AZ,
Sponsor: Qurient Co., Ltd.
Sex: All
Age: 18+
Code: NCT05394103
Phase1, Phase2, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)